CLINICAL_TRIALS
trial_result
· 2018-06-21
Clinical Trial Update: Effect of Danazol on Endometrial αvβ3 Integrin Expression in Patients With Unexplained Recurrent Implantation Failure [Phase 3]
Summary
Phase 3 trial evaluating Danazol's effect on endometrial αvβ3 integrin expression in patients with unexplained recurrent implantation failure; trial status is c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ain Shams University | Conditions: Unexplained Infertility | Phase 3 | Status: COMPLETED